ES2033823T3 - Ensayo en cuanto a cancer de mama humano. - Google Patents

Ensayo en cuanto a cancer de mama humano.

Info

Publication number
ES2033823T3
ES2033823T3 ES198787301040T ES87301040T ES2033823T3 ES 2033823 T3 ES2033823 T3 ES 2033823T3 ES 198787301040 T ES198787301040 T ES 198787301040T ES 87301040 T ES87301040 T ES 87301040T ES 2033823 T3 ES2033823 T3 ES 2033823T3
Authority
ES
Spain
Prior art keywords
breast cancer
trial
human breast
serums
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787301040T
Other languages
English (en)
Spanish (es)
Inventor
Peter S. Linsley
Vincent W. Ochs
Diane Horn
Joseph P. Brown
David B. Ring
Arthur E. Frankel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Cetus Oncology Corp
Original Assignee
Oncogen LP
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25246638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2033823(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oncogen LP, Cetus Oncology Corp filed Critical Oncogen LP
Application granted granted Critical
Publication of ES2033823T3 publication Critical patent/ES2033823T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES198787301040T 1986-02-05 1987-02-05 Ensayo en cuanto a cancer de mama humano. Expired - Lifetime ES2033823T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/826,477 US4803169A (en) 1986-02-05 1986-02-05 Assay for human breast cancer

Publications (1)

Publication Number Publication Date
ES2033823T3 true ES2033823T3 (es) 1993-04-01

Family

ID=25246638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787301040T Expired - Lifetime ES2033823T3 (es) 1986-02-05 1987-02-05 Ensayo en cuanto a cancer de mama humano.

Country Status (9)

Country Link
US (1) US4803169A (https=)
EP (1) EP0232179B1 (https=)
JP (1) JP2739110B2 (https=)
AT (1) ATE78601T1 (https=)
AU (1) AU593476B2 (https=)
CA (1) CA1279006C (https=)
DE (1) DE3780480T2 (https=)
ES (1) ES2033823T3 (https=)
GR (1) GR3005971T3 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401638A (en) * 1986-06-04 1995-03-28 Oncogene Science, Inc. Detection and quantification of neu related proteins in the biological fluids of humans
US6861511B1 (en) 1986-06-04 2005-03-01 Bayer Corporation Detection and quantification of neu related proteins in the biological fluids of humans
AU613590B2 (en) * 1986-11-19 1991-08-08 Bristol-Myers Squibb Company Hybridomas producing monoclonal antibodies to new mucin epitopes
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
EP0394510A1 (en) * 1989-04-24 1990-10-31 Mochida Pharmaceutical Co., Ltd. Method for assaying a tumor-associated antigen in a minute amount of nipple discharge and device for such an assay
EP0491867B1 (en) * 1989-09-15 1996-11-27 Genetic Systems Corporation Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
US5411868A (en) * 1989-10-24 1995-05-02 Board Of Regents, The University Of Texas System Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy
AU7316391A (en) * 1990-01-25 1991-08-21 State of Oregon acting by and through the The State Board of Higher Education on Behalf of the Oregon Health Sciences University, The Detection of a characteristic antigen from carcinoma in body fluids
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
WO1994010343A1 (en) * 1992-10-29 1994-05-11 Thomas Jefferson University Methods of detecting micrometastasis of prostate cancer
US5763164A (en) * 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522918A (en) * 1981-12-15 1985-06-11 Jeffery Schlom Process for producing monoclonal antibodies reactive with human breast cancer
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer
US4657851A (en) * 1984-01-03 1987-04-14 Georgetown University Breast cancer diagnostic blood test
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
EP0160446B1 (en) * 1984-05-01 1992-06-17 Ciba Corning Diagnostics Corp. Breast tumor-associated antigen and monoclonal antibodies specific thereto
WO1986004092A1 (fr) * 1984-12-28 1986-07-17 Taisho Pharmaceutical Co., Ltd. Procede de preparation d'un anticorps monoclonal specifique du cancer humain
AU601379B2 (en) * 1985-11-07 1990-09-13 Trustees Of Columbia University In The City Of New York, The Antigen indicative of human breast cancer and assays based thereon

Also Published As

Publication number Publication date
JP2739110B2 (ja) 1998-04-08
EP0232179A2 (en) 1987-08-12
GR3005971T3 (https=) 1993-06-07
EP0232179B1 (en) 1992-07-22
AU593476B2 (en) 1990-02-08
CA1279006C (en) 1991-01-15
JPS62259064A (ja) 1987-11-11
EP0232179A3 (en) 1989-09-06
ATE78601T1 (de) 1992-08-15
US4803169A (en) 1989-02-07
DE3780480T2 (de) 1993-02-18
DE3780480D1 (de) 1992-08-27
AU6828387A (en) 1987-08-06

Similar Documents

Publication Publication Date Title
Baldwin et al. Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
Zone et al. Circulating immune complexes of IgA type in dermatitis herpetiformis
UA24003A (uk) Спосіб визhачеhhя специфічhої сеhсибілізації лімфоцитів
Canevari et al. Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease
NO153910C (no) Direkte agglutineringsproeve for paavisning av antigener i kroppsvaesker.
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
FI810007A7 (fi) Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille.
Hancock et al. HMB-45 detection in adenocarcinomas
Sofen et al. Anti-squamous tumor antibodies in patients with squamous cell carcinoma
NO862097L (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinoma.
Muller et al. Immunofluorescent staining of rat gastric parietal cells by human antibody unrelated to pernicious anaemia
Murray et al. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients
ES8206857A1 (es) Procedimiento de deteccion de la presencia de antigenos de un grupo sanguineo a,b,0 o ab en un corte histologico
Toussaint et al. An indirect fluorescent antibody technique using soluble antigens for serodiagnosis of Trypanosoma cruzi infection
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
ES2050171T3 (es) Anticuerpo monoclonal capaz de reconocer arterioesclerosis humana y proceso para prepararlo.
Leblanc et al. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells
Emmrich et al. Leucocyte migration inhibition under agarose versus MEM test for detection of tumour-associated antigens
Ronai et al. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients
SE8306661D0 (sv) Forfarande och test-sats for diagnostisering av cancer pa menniskor
GB1413800A (en) Diagnosis of viral diseases
Vanhaelst et al. Immunofluorescent technique and long acting thyroid stimulator in human serum
Lockyer Laboratory investigation of the immune alpha and beta antibodies and their corresponding haemolysins in maternal and cord sera; with special reference to the selection of the reagents used to establish their presence